Israeli biotech Brainstorm has received a US patent for its autologous stem cell technology for the treatment of neuro-degenerative diseases. Brainstorm is preparing for its US upcoming multi-center Phase II trial with its proprietary NurOwn stem cell therapy. http://www.brainstorm-cell.com/index.php/news-a-events/291-march-24-2014

Scientists from Israel’s Weizmann Institute have revealed the sophisticated mechanism that the digestive system uses to balance good and bad bacteria. A protein cluster called inflammasome monitors the bacterial population and signals the secretion of antibiotic proteins. http://wis-wander.weizmann.ac.il/goblet-cells-get-their-germs#.Uy8V286oVey

The US FDA has just approved the MUSE system from Israel’s Medigus. MUSE is a unique medical device that allows doctors to examine the stomach and esophagus with a tiny camera. The same device can then be used to stop … Continue reading →

Israel’s Itamar Medical has signed an exclusive marketing agreement with Medtronic Corporation to market the company’s sleep apnea diagnostic product to a select segment of the US market – patients with atrial fibrillation.. http://www.globes.co.il/en/article-itamar-signs-medtronic-distribution-deal-for-sleep-device–1000925010

Israel’s Amorphical has successfully completed a clinical trial of its amorphous calcium. The trial found that the patients’ absorption of amorphous calcium was double the average absorption of crystalline calcium. Amorphical aims to develop a product as a nutritional supplement. … Continue reading →

Cardiologist Prof. Ilan Goldenberg from Israel’s Sheba Medical Center led an international study into cardiac insufficiency – also known as heart failure. It reported that an automatic cardiac pacemaker/defibrillator implanted at an early stage of common heart failure could extend … Continue reading →